1. Home
  2. PCRX vs ESQ Comparison

PCRX vs ESQ Comparison

Compare PCRX & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.63

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$106.30

Market Cap

858.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
ESQ
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
858.2M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
PCRX
ESQ
Price
$26.63
$106.30
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
$32.86
$113.00
AVG Volume (30 Days)
723.2K
72.0K
Earning Date
11-06-2025
01-22-2026
Dividend Yield
N/A
0.65%
EPS Growth
N/A
14.70
EPS
0.47
5.68
Revenue
$716,791,000.00
$131,743,000.00
Revenue This Year
$6.24
N/A
Revenue Next Year
$9.53
$18.55
P/E Ratio
$55.78
$18.88
Revenue Growth
3.14
13.37
52 Week Low
$18.17
$68.90
52 Week High
$27.64
$108.55

Technical Indicators

Market Signals
Indicator
PCRX
ESQ
Relative Strength Index (RSI) 73.86 64.21
Support Level $25.17 $100.63
Resistance Level $24.81 $108.55
Average True Range (ATR) 0.94 2.88
MACD 0.28 0.48
Stochastic Oscillator 89.16 78.68

Price Performance

Historical Comparison
PCRX
ESQ

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: